← Back to Search

Combined serratus anterior plane block and transversus thoracis plane block for Implantable Cardioverter Defibrillators

N/A
Waitlist Available
Research Sponsored by New York Presbyterian Brooklyn Methodist Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights

Study Summary

This trial will compare two ways of numbing patients undergoing SICD implantation to see which is more effective at reducing pain.

Eligible Conditions
  • Subcutaneous Implantable Cardioverter Defibrillator
  • Serratus Anterior Plane Block
  • Transversus Thoracis Plane Block

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~intraoperative
This trial's timeline: 3 weeks for screening, Varies for treatment, and intraoperative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Postoperative pain score measured
Secondary outcome measures
Block related complications
Intraoperative hemodynamics
Intraoperative pain score measured
+6 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Combined serratus anterior plane block and transversus thoracis plane blockExperimental Treatment1 Intervention
The study group will receive a combined plane block by a dedicated anesthesia team prior to their procedure. 20 mL of local anesthetic (0.25% bupivacaine) will be injected for the Serratus anterior plane block and another 20 mL of local anesthetic (0.25% bupivacaine) will be injected in transversus thoracis plane block
Group II: Stand local anesthetic infiltrationActive Control1 Intervention
Local anesthetic infiltration of the incision sites will be performed by the cardiologist prior to, and as, necessary during the procedure. The amount of local anesthetic used will be determined intraoperatively by the cardiologist according to the patients' requirements.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Combined serratus anterior plane block and transversus thoracis plane block
2021
N/A
~30

Find a Location

Who is running the clinical trial?

New York Presbyterian Brooklyn Methodist HospitalLead Sponsor
18 Previous Clinical Trials
3,732 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant count for this research project?

"Yes, according to clinicaltrials.gov, this research project is presently seeking participants. It was initially made available on February 24th 2021 and its details were last updated on April 4th 2022. This study requires a total of 24 volunteers from 1 hospital or clinic."

Answered by AI

Is this research endeavor currently recruiting participants?

"Confirmed, according to data on clinicaltrials.gov this medical study is actively looking for participants. This trial was launched on February 24th 2021 and the most recent update occurred April 4th 2022, with a recruitment goal of 24 patients from 1 site."

Answered by AI
Recent research and studies
~6 spots leftby Apr 2025